Figure 5
Figure 5. GATA2 patients have unique transcript profiles compared with healthy normals and diseased controls. Normalized transcript counts from nCounter analysis used for (A) 2-dimensional principal component analysis of patients with GATA2 i5C>T (patients 4.II.1, 11.II.1, 25.I.1), missense mutation (GATA2 Mis; patients 15.I.1, 19.II.1, 30.II.1), and reduced allelic expression without identified GATA2 mutation (GATA2 Unk; patients 7.I.1, 29.I.1) compared with healthy controls and diseased controls with similar infection types but wild-type GATA2. Fungal, disseminated coccidioidomycosis or histoplasmosis; Mycobacteria, disseminated mycobacteria; Cryptosporidiosis, disseminated cryptosporidium. (B) Hierarchical clustering of transcripts differentially regulated (P < .05) between healthy normals and GATA2 mutated patients irrespective of genotype. Samples and color labels correspond to mutations as in A.

GATA2 patients have unique transcript profiles compared with healthy normals and diseased controls. Normalized transcript counts from nCounter analysis used for (A) 2-dimensional principal component analysis of patients with GATA2 i5C>T (patients 4.II.1, 11.II.1, 25.I.1), missense mutation (GATA2 Mis; patients 15.I.1, 19.II.1, 30.II.1), and reduced allelic expression without identified GATA2 mutation (GATA2 Unk; patients 7.I.1, 29.I.1) compared with healthy controls and diseased controls with similar infection types but wild-type GATA2. Fungal, disseminated coccidioidomycosis or histoplasmosis; Mycobacteria, disseminated mycobacteria; Cryptosporidiosis, disseminated cryptosporidium. (B) Hierarchical clustering of transcripts differentially regulated (P < .05) between healthy normals and GATA2 mutated patients irrespective of genotype. Samples and color labels correspond to mutations as in A.

Close Modal

or Create an Account

Close Modal
Close Modal